Determination of heparin in blood plasma

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 12, 23230B, G01N 3316, A61K 4300

Patent

active

042028728

ABSTRACT:
A test for determining the anti-coagulation level in blood samples is based on ascertaining the presence of heparin-antithrombin-III complex therein. This may be done with the aid of antibodies against thrombin-antithrombin-III complex, such antibodies being used e.g. in the form of a latex reagent or a bloodcell reagent.

REFERENCES:
Merskey et al., Proc. Soc. Exp. Biol. Med., vol. 131, No. 3, Jul., 1969, pp. 871-875.
Einarsson et al., Biochemica et Biphysica Acta, vol. 490, No. 1, Jan., 1977, pp. 104-111.
Collin et al., Thrombosis Research, vol. 7, No. 1, Jul., 1975, pp. 235-238.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Determination of heparin in blood plasma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Determination of heparin in blood plasma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Determination of heparin in blood plasma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-929741

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.